Compounded tirzepatide online,
$219 a month
Updated October 2026
Independent medical content review by Feyo Edo Ambia, MD
Compounded tirzepatide is $219 a month on a one-month plan. Prepaid 3-month and 6-month supplies cost $645 ($215 a month) and $1,260 ($210 a month). A licensed provider reviews your intake before any prescription. If one is written, the medication ships to your door. Insurance is not billed.
- Medication if prescribed
- Provider review before any prescription
- Shipping included if prescribed
- See the full pricing
- Start the intake
Prescription required. Not everyone qualifies. Individual results vary.
Compounded tirzepatide
One flat monthly price, all doses. Reviewed by an independent licensed provider.
Medication included if prescribed. No membership fee, no hidden charges, no insurance required.
Start intakeTreatment determined by licensed providers. Not all patients qualify.
Online compounded tirzepatide
Surfbound Health offers compounded tirzepatide online for $219 a month. Medication and shipping are included once a licensed provider determines treatment is appropriate. Pricing is flat, with no separate membership fee and no dose-based price increase.
Who this is for
- Adults seeking a clinician’s assessment for weight management
- People who prefer one flat, cash-pay monthly price, which is a service preference rather than a clinical indication
- Anyone who would rather not wait on insurance or prior authorization, which is also a service preference rather than a clinical indication
- Patients switching providers who want a clinician to review their current treatment
Common questions before choosing Surfbound
- Can I do the whole process online?
- Yes, if you want it handled end to end without waiting rooms or scheduled visits. You complete a short online intake on your own schedule, a licensed provider reviews your case, and if prescribed, medication ships discreetly to your door.
- Do you treat women over 40?
- Surfbound offers provider-reviewed options for eligible adult women, including many in their 40s, 50s, and 60s. A licensed provider reviews your health history before deciding whether treatment is appropriate, and pricing stays flat each month with no membership fee.
- Can you match my dose if I switch?
- Surfbound accepts patients switching from other providers and aims to match your current dose, subject to a licensed provider's review of your history. You pay one flat monthly price with no membership fee and no dose-based upcharge.
- Is compounded tirzepatide the same as Mounjaro or Zepbound?
- No. Compounded tirzepatide is made by a compounding pharmacy. It is not an FDA-approved finished drug product, and the FDA does not review it for safety, effectiveness, or quality the way it reviews Mounjaro or Zepbound. It costs $219 a month with no membership fee.
- Can I start without insurance?
- You can request an evaluation without insurance. Treatment still depends on clinical eligibility and whether a compounded medicine is appropriate. Surfbound is a cash-pay platform, so no insurance approval or prior authorization is needed to begin the evaluation. If your plan excludes anti-obesity medication, you are not blocked: you pay one flat monthly price with no membership fee, and nothing is charged unless a licensed provider approves your medication.
- How do I reach support?
- Yes. Surfbound Health support is reachable by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday-Friday, 9:00 AM-5:00 PM ET) and existing patients at (813) 532-3185 (Monday-Friday, 9:00 AM-5:00 PM MST). You can ask anything about treatment without booking another appointment. Surfbound is not an emergency service: for trouble breathing, swelling of the face, lips, tongue or throat, collapse, or another life-threatening reaction, call 911 rather than waiting for a support reply.
- What does it cost each month?
- Surfbound uses flat, published monthly pricing with no separate membership fee and no dose-based increase. Provider review, medication, and discreet shipping are included when prescribed, so the monthly price is the full cost.
Start your tirzepatide evaluation online
Start with the online intake. A licensed provider reviews it before anything is prescribed.
- Flat cash-pay pricing with no membership fee
- Licensed provider review before any prescription
- Medication and shipping included when prescribed
- Month-to-month structure
Payment options: The one-month plan is billed one month at a time. Optional 3 and 6 Month packages are charged in full at the start of each period, ship together as one package, and renew automatically at the same price every 3 or 6 months until you cancel in your patient portal. Compare the plan totals before choosing.
Who provides care: Surfbound Health is a trade name of Open Water Rx LLC. Medical decisions rest with the care team; a dispensing pharmacy supplies medication if prescribed. Pharmacy information · State availability · Refund terms.
Treatment requires a licensed-provider review. Prescriptions are not guaranteed.
What does tirzepatide cost at Surfbound Health?
Surfbound Health charges one flat price of $219/mo for compounded tirzepatide at every dose, so a stronger prescription does not raise your bill. There is no membership fee and no separate consultation fee, and no insurance is required. What that figure covers is set out just below.
| Supply | Total | Get started |
|---|---|---|
| 1 month | $219 | Start with this plan |
| 3 months (prepaid) | $645 | Start with this plan |
| 6 months (prepaid) | $1,260 | Start with this plan |
Multi-month bundles are prepaid and lower your effective monthly cost.
Medication included
Compounded tirzepatide is included if a licensed provider prescribes it.
Provider review
An independent licensed provider reviews your full health history.
No hidden fees
Nothing is added at checkout. The monthly figure is the whole bill.
Discreet shipping
Medication ships to your door in discreet packaging if prescribed.
Membership fee
$0
Dose-based price increase
None
Commitment
Monthly plan; optional prepaid packages
Provider review
Included
Medication
Included if prescribed
Shipping
Included if prescribed
Compare the figure above against every other treatment on the full pricing breakdown, or start your tirzepatide intake.
Before you switch
Already on a GLP-1 from another provider? You don't have to start over. At the end of signup, use your doctor notes to tell the reviewing provider two things:
- Your current medication and dosage
- Whether you want to keep your current dose or discuss progressing
Prescribing remains subject to licensed clinician review.
Help with your program
Clear cash-pay pricing, and straightforward support you can reach before or after you start.
Support center
Shipping, billing, refills, and account help in one place.
Contact us
Questions before you start? Reach the team directly.
Cancellation & refunds
Cancel anytime. See exactly when refunds apply.
Prefer email? Reach us at hello@surfbound.co.
How online tirzepatide treatment works
Starting tirzepatide through Surfbound Health is a three-step process, all online, from your phone or computer.
Complete your online intake
Answer a short, secure health questionnaire from home in about 5–10 minutes. No appointment, no waiting room.
Licensed provider reviews your case
An independent licensed provider reviews your health history and determines whether tirzepatide is medically appropriate. Typically within 1–2 business days.
Medication ships if prescribed
If treatment is prescribed, medication ships discreetly from a pharmacy partner with supplies and instructions.
Who may be eligible?
For weight management, FDA-approved Zepbound is used with a reduced-calorie diet and increased physical activity in adults with obesity, generally BMI 30 or higher, or overweight, generally BMI 27 or higher, with at least one weight-related health condition. These are approved-product criteria, not a guarantee of eligibility for a compounded prescription.
A licensed provider must assess your medical history, current medicines and treatment needs. Meeting a BMI threshold does not by itself establish that compounded treatment is appropriate. Compounded medicines should be considered only when an FDA-approved medicine cannot meet the patient’s medical needs.
Do not use: Do not use tirzepatide if you have a personal or family history of medullary thyroid carcinoma (MTC), have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or have had a serious allergic reaction to tirzepatide or an ingredient in the prescribed product.
Tell the prescriber about pancreatitis, severe stomach or digestion problems, kidney problems, diabetic eye disease, insulin or sulfonylurea use, planned surgery or sedation, pregnancy plans and breastfeeding. Approved tirzepatide is not recommended for people with severe gastroparesis. The clinician must assess these issues individually.
- Treatment is determined by a licensed provider after reviewing your full health history.
- Not everyone qualifies: prescription is never automatic.
- You are billed only after your medication is approved.
How quickly can I start?
The intake takes about 5–10 minutes. A licensed provider typically reviews your case within 1–2 business days. If prescribed, medication ships after pharmacy processing, often within about 1–2 days, though timing varies by pharmacy and location. Tracking is provided.
For a fuller explanation of what to expect, read our GLP-1 beginners guide.
Where is my prescription filled?
If treatment is prescribed, the prescription is sent through Surfbound’s pharmacy fulfillment process to an appropriate licensed pharmacy partner. Surfbound is not a pharmacy and does not compound or dispense medication.
See Surfbound’s pharmacy partnersTirzepatide vs semaglutide
Surfbound Health offers both compounded tirzepatide and compounded semaglutide. A licensed provider determines which option, if any, is clinically appropriate for you.
| Medication | Class | Monthly price | How it works |
|---|---|---|---|
| Tirzepatide | Dual GIP/GLP-1 receptor agonist | $219/mo | Once-weekly injection. Acts on GIP and GLP-1 receptors and delays stomach emptying. |
| Semaglutide | GLP-1 receptor agonist | $169/mo | Once-weekly injection. Reduces appetite and slows gastric emptying. |
Want a deeper breakdown of the differences? Read semaglutide vs tirzepatide or, if you are weighing brand-name Zepbound against a compounded option, see Zepbound alternatives. Whichever option fits, a licensed provider decides: one flat price at every dose, with the medication if prescribed and discreet shipping included. Curious where you stand? Check eligibility.
What affects the total cost of tirzepatide?
The sticker price isn’t always the full picture. When comparing tirzepatide programs, watch for these common add-ons.
Membership and consult fees
Some providers charge a separate monthly membership on top of medication. Surfbound Health bundles everything into one flat monthly price: no membership fee, no consult fee.
Dose-based price increases
Some plans raise the price as your dose increases. Surfbound Health charges the same price at every dose of compounded tirzepatide.
Shipping and supplies
Look for hidden shipping or supply charges. With Surfbound Health, discreet shipping is included in the monthly price if prescribed.
Insurance and self-pay
Surfbound Health is a cash-pay service. You pay one flat monthly price out of pocket, and no insurance is required. Because compounded medications are typically not covered by insurance, transparent self-pay pricing helps you know your exact cost upfront, without surprise bills or coverage denials.
Paying out of pocket? See the full breakdown of tirzepatide cost without insurance.
Estimate your full out-of-pocket cost with the GLP-1 total cost calculator.
Choosing an online provider
Tirzepatide programs look similar at first glance, but pricing structure, review standards, and transparency vary widely. Here’s how Surfbound Health approaches it.
Transparent, flat pricing
One price at every dose, with no membership fee, no consult fee, and no hidden charges. The price you see is what you pay.
Licensed provider review
Every case is reviewed by an independent licensed provider who determines whether treatment is medically appropriate.
No insurance needed
No insurance, no prior authorization, no surprise bills. You pay one clear cash-pay price and know exactly what you’ll pay before you start.
Privacy and discretion
Secure intake, discreet packaging, and no requirement to visit a clinic or share your journey publicly.
Our pricing philosophy
One flat monthly price covers your medication if prescribed, licensed provider review, ongoing dosing support, and discreet shipping, with no membership fee, no consult fee, and no insurance required. We believe you should be able to see exactly what you’ll pay before you start.
Safety and important limitations
Tirzepatide is a prescription medication with real risks. Here’s what you should know before starting.
Compounded status
Compounded tirzepatide is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. FDA advises that compounded drugs should be used only when a patient’s medical needs cannot be met by an FDA-approved drug. A lower price or lack of insurance does not by itself establish that clinical need. A licensed provider must assess the individual situation.
- Treatment is subject to a licensed provider’s clinical review. Not everyone qualifies, and prescription is never automatic.
- FDA-approved tirzepatide products carry a boxed warning: tirzepatide caused thyroid C-cell tumors in rats. It is not known whether this occurs in humans. Tell your prescriber about a neck lump, persistent hoarseness or trouble swallowing. Trouble breathing needs urgent assessment.
- Do not use tirzepatide if you have a personal or family history of medullary thyroid carcinoma (MTC), have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or have had a serious allergic reaction to tirzepatide or an ingredient in the prescribed product.
- Individual results vary. There is no guaranteed weight loss, and no specific outcome is promised.
- Common side effects reported with approved tirzepatide include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, belching, reflux, fatigue, injection-site reactions, allergic reactions and hair loss. Digestive symptoms often occur during dose increases and may lessen over time. Severe or persistent symptoms need medical advice; see ‘When to get medical help’.
Serious risks
Important risks include severe digestive problems, dehydration that can lead to kidney injury, gallbladder disease, pancreatitis, serious allergic reactions, and low blood sugar, especially when used with insulin or a sulfonylurea. People with type 2 diabetes should discuss diabetic eye disease and report vision changes. Tell your surgical and anesthesia team that you take tirzepatide before procedures involving general anesthesia or deep sedation because delayed stomach emptying can increase aspiration risk. Do not decide on a pre-procedure stopping schedule yourself.
When to get medical help
- Call 911 for trouble breathing, swelling of the face, lips, tongue or throat, collapse, or another life-threatening reaction. Do not wait for a Surfbound support reply.
- Stop tirzepatide and seek medical help right away for severe, persistent abdominal pain, which may spread to the back, with or without vomiting, or for a suspected serious allergic reaction.
- Seek prompt medical care if vomiting or diarrhea prevents you from keeping fluids down, you feel faint, or you have signs of dehydration. Upper abdominal pain with fever, yellow skin or eyes, or pale/clay-colored stools also needs prompt assessment. Do not wait for a 24-hour threshold if symptoms are severe.
- Contact your prescriber promptly about new vision changes, a neck lump, persistent hoarseness or difficulty swallowing. Severe breathing difficulty is an emergency. Follow the low-blood-sugar plan given by your clinician; severe confusion, seizure or loss of consciousness requires emergency help.
- For mild side effects, follow your prescribed care plan and contact your clinician if symptoms persist or worry you. Do not increase or change doses yourself.
Surfbound is not an emergency service. Customer-support availability is separate from urgent medical care. Suspected medication side effects can also be reported to FDA MedWatch at 1-800-FDA-1088 or through FDA's MedWatch website.
Pregnancy, birth control and breastfeeding
Tell your prescriber if you are pregnant, could become pregnant, are planning pregnancy, or are breastfeeding. Tirzepatide used for weight management should be stopped when pregnancy is recognized. Weight loss offers no benefit during pregnancy, and tirzepatide may harm the fetus. Contact your prescriber promptly if pregnancy occurs or is suspected.
If you use birth control pills, tirzepatide can reduce their effectiveness. The US prescribing information advises switching to a non-oral contraceptive or adding a barrier method, such as condoms, for 4 weeks after starting and for 4 weeks after every dose increase. Discuss the change with your prescriber. Hormonal contraception that is not taken by mouth is not expected to be affected by tirzepatide’s effect on stomach emptying. Vomiting or severe diarrhea may also affect oral contraception; ask your pharmacist or prescriber for instructions specific to your pill and how long symptoms last.
Planning pregnancy: arrange a medication and pregnancy plan with your prescriber before trying to conceive. The US Zepbound label does not specify a preconception stopping interval. UK guidance advises stopping tirzepatide at least 1 month beforehand; your prescriber should individualize your plan.
Breastfeeding: a small study after one tirzepatide dose found very low or undetectable levels in breast milk. This does not establish safety for infants during ongoing treatment. Effects on infants and milk production remain uncertain. Discuss your treatment needs and breastfeeding with your prescriber before use.
Dosing and treatment changes
The FDA-approved Zepbound injection schedule starts at 2.5 mg once weekly for 4 weeks, then 5 mg once weekly. Further increases are in 2.5 mg steps after at least 4 weeks at the current dose; the maximum recommended dose is 15 mg once weekly. The 2.5 mg dose is for initiation. Maintenance dose selection depends on response and tolerability; escalation is not automatic.
This schedule describes the approved product, not an individualized prescription for Surfbound’s compounded medication. Follow your prescriber’s instructions. Do not start at 15 mg, increase faster, reuse old syringe-unit instructions, or decide how to restart after a gap without clinical advice.
Weight management often needs a long-term plan. In a clinical trial of approved tirzepatide, people who stopped treatment and switched to placebo regained weight on average, while those who continued maintained and increased their weight loss. Discuss ongoing care and any decision to stop with your prescriber. These findings do not establish outcomes for a particular compounded product.
Reference: Zepbound (tirzepatide) US prescribing information.
Dose units, vials and storage
A dose in milligrams (mg), a liquid volume in milliliters (mL), and syringe markings are different measurements. Before injecting, have your pharmacist or prescriber confirm the prescribed mg dose, the concentration in mg/mL, the volume in mL, and the correct marking on your supplied syringe. If any part is unclear, do not guess or inject until it is clarified. Never transfer syringe-unit instructions between different concentrations.
For compounded GLP-1 medicine supplied in a multidose vial, FDA advises discarding the vial within 28 days after first use, even if medicine remains or compounder directions allow longer. Follow an earlier discard date if given. Use a new sterile needle and syringe for every dose. Unopened storage and expiry instructions are separate.
Check the medication and storage instructions when it arrives. FDA advises not using an injectable GLP-1 medicine that arrives warm or without adequate refrigeration. Contact the dispensing pharmacy or prescriber before using an affected shipment. Store the medication as instructed for the exact dispensed product; do not assume a brand-name pen's room-temperature allowance applies to a compounded vial.
Reference: FDA guidance on unapproved GLP-1 drugs used for weight loss.
This page provides general information and is not medical advice. Always rely on the judgment of a licensed provider for individualized guidance. Review our safety information and GLP-1 side effects guide. Before your first injection, read our explanation of why tirzepatide starting doses and concentration checks matter. Ask your own prescriber or pharmacist to confirm your prescription before use.
Sources
The safety and eligibility information on this page is drawn from the following public sources. They are general references, not a substitute for a licensed provider's assessment of your own situation.
- 1Zepbound (tirzepatide) prescribing information, current version — Warnings, contraindications, oral-contraceptive interaction, pregnancy and adverse reactions.
- 2FDA — Concerns with unapproved GLP-1 drugs used for weight loss — Why FDA advises using compounded drugs only when an approved drug cannot meet a patient’s needs.
- 3FDA — Human drug compounding — Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality.
- 4CDC — U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 — Guidance on contraceptive choice when a medicine can affect effectiveness.
- 5UK government — GLP-1 medicines for weight loss and diabetes: what you need to know — UK guidance on stopping tirzepatide before a planned pregnancy.
- 6LactMed (NIH) — Tirzepatide — Drug levels in breast milk and what remains unknown during ongoing treatment.
- 7SURMOUNT-4 — Continued versus withdrawn tirzepatide treatment (JAMA) — What happened to weight after treatment stopped versus continued.
- 8Mounjaro (tirzepatide) US prescribing information, FDA — Approved indication for type 2 diabetes in the US.
Medical content review
Reviewed by Feyo Edo Ambia, MDDoctor of Medicine, Arba Minch University, Ethiopia.
Independent medical content review for clinical accuracy, commissioned by Surfbound Health. This is not an endorsement of Surfbound Health or its products.
Final verification of this page was completed on . The review concerns medical accuracy and safety information; it does not certify Surfbound's clinical operations or billing terms.
Frequently asked questions
Surfbound Health charges a flat $219/month for compounded tirzepatide, regardless of dose. A stronger prescription does not raise your bill, and no separate consultation or membership charge applies.
Yes. You complete a secure online intake, and an independent licensed provider reviews your health history. If treatment is clinically appropriate, the provider sends a prescription to a pharmacy partner, and medication ships to your door.
You can request an evaluation without insurance. Treatment still depends on clinical eligibility and whether a compounded medicine is appropriate. Surfbound Health is cash-pay, which means you pay one flat monthly price out of pocket. No insurance is required, and there are no surprise add-on fees at checkout.
The monthly price includes the compounded tirzepatide medication (if prescribed), licensed provider review, ongoing clinical oversight and dose adjustments, secure messaging, and discreet shipping. There are no hidden membership or consult fees.
At Surfbound Health, compounded tirzepatide is $219/month compared to $169/month for compounded semaglutide. Tirzepatide is a dual GIP/GLP-1 receptor agonist, while semaglutide is a GLP-1 receptor agonist. A licensed provider determines which option, if any, is appropriate for you.
After you complete the intake, an independent licensed provider reviews your full health history, typically within 1–2 business days. The provider may request more information before deciding. A prescription is not guaranteed. If treatment is prescribed, medication ships after pharmacy processing, often within about 1–2 days, though timing varies by pharmacy and location. Tracking is provided.
Yes. Tirzepatide is a prescription medication. A licensed provider must review your health history and determine whether it is medically appropriate before any prescription is issued. Not everyone qualifies.
No. Mounjaro® and Zepbound® are FDA-approved brand-name tirzepatide medications. Compounded tirzepatide is prepared by licensed compounding pharmacies and is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. In the US, Mounjaro is approved for type 2 diabetes, while Zepbound is approved for weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity. Surfbound’s compounded preparation carries none of those approvals. A licensed provider determines whether treatment is appropriate for you.
Nothing is charged unless your medication is approved. Prescription is never automatic: it depends entirely on the provider’s clinical review of your health history. Your provider may recommend discussing other options with your usual clinician.
Tirzepatide requires evaluation and a prescription from a licensed provider. Surfbound offers online provider review for eligible adults, with compounded tirzepatide included and shipped if prescribed, at a flat $219/month. A prescription is not guaranteed. A licensed provider determines whether treatment is appropriate for you.
Start your tirzepatide intake
Start your intake in a few minutes. A licensed provider evaluates whether tirzepatide suits your health profile, and if it's prescribed, it ships straight to your door. Payment is only taken after approval.
Start onlineTirzepatide is prescription-only, and qualification varies.